Exploring the statistics behind neuroblastoma in the UK
A closer look into the National Cancer Registration and Analysis Service (NCRAS) 2021 report on cancer in children, teenagers and young adults.
Research explainer: Single cell study finds sympathoblasts as the root of neuroblastoma
We had We had the opportunity to speak with one of the lead authors of this work, Dr. Jan Molenaar of the Princess Máxima Centre about its significance and what it means for patients.
Research update- March 2021
We have started the year with a new addition to the research team, our Research and Digital Comms Officer Emily Hall who will be focused on sharing and celebrating our research work and helping families navigate the world of neuroblastoma research.
Celebrating women in research: Getting to know Dr Emma Pond
In honour of the International Day for Women and Girls in Science, we've been chatting to our Senior Trials Coordinator Dr Emma pond about her role and the fantastic work she does for SKC.
Advances in Neuroblastoma Research conference 2021
Every 2 years the Advances in Neuroblastoma Research conference invites researchers and clinicians worldwide who work in the field of neuroblastoma to come together and share their latest work.
Research update- December 2020
We are delighted to have announced the first International Neuroblastoma Research Initiative award to be funded under our AMRC-accredited research funding process, which will see a targeted drug introduced to frontline treatment for children with the hope
Research update - September 2020
This Autumn we are extremely busy with our ongoing International Neuroblastoma Research Initiatives.
Research update- July 2020
The impact of COVID-19 has been serious and will have long-lasting consequences for medical research in the UK, not least because so much of our medical research is funded by charities.
Research update - May 2020
The coronavirus pandemic has brought new challenges to our ongoing research programme, as we work with experts worldwide to bring more, better and less toxic treatment to children in the UK and beyond.
